Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results for Vascular Normalization Therapy  AV-001 was Safe and Well-Tolerated in Healthy Volunteers  Vasomune plans to initiate a Phase 2a proof-of-concept study…

Vasomune is very pleased to announce that the company has received a substantial investment on behalf of the Government of Canada through the National Research Council (NRC) for Vasomune's continued…